Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Vivodyne logo — We accelerate the discovery of cures to human diseases with...

Vivodyne

We accelerate the discovery of cures to human diseases with ultra-scalable drug testing on lab-grown human tissues.

Founded 2020 United States Philadelphia, United States 40 employees Seed Total: $40.00M Biotechnology, Lifestyle

General Information

Company Name Vivodyne
Founded Year 2020
Location United States Philadelphia, United States
Employees 40
Industries Biotechnology, Lifestyle
Funding Stage Seed
Business Model B2B, Platform, SaaS
Revenue Model Service Fee, Usage Based, Performance Based
Social

BounceWatch is an independent company data service, not affiliated with Vivodyne. To contact Vivodyne, visit vivodyne.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Vivodyne compare?

A PDF of Vivodyne and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Vivodyne soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Vivodyne

Vivodyne, founded in 2020, is a cutting-edge player in the Biotechnology and Lifestyle industries. Their motto, "We accelerate the discovery of cures to human diseases with ultra-scalable drug testing on lab-grown human tissues," succinctly captures their mission to revolutionize drug discovery processes.

This United States-based startup is at the forefront of utilizing lab-grown 3D human tissues for scalable drug testing, potentially transforming how treatments for human diseases are discovered and developed. Its technology promises to expedite the drug discovery timeline significantly, targeting a critical bottleneck in medical research.

Vivodyne recently secured a significant financial backing of $38.00M in a Seed Round on 22 November 2023. This investment round attracted notable investors, including Khosla Ventures, Kairos Ventures, Bison Ventures, MBX Capital, and CS Venture Opportunities Fund. Their involvement underscores confidence in Vivodyne's innovative approach and growth potential.

Business keywords: drug discovery, robotic systems, cellular therapies, lab-grown tissues, automated technology, disease cures, 3D tissue culturing, drug testing, human health, biomedical research

Services & Products

Development of lab-grown human organ models
AI-driven drug discovery and testing
Automation of massive-scale human tissue studies
Provision of preclinical human data for new therapies

Target Customers

Biopharma companies Pharmaceutical researchers Drug developers Healthcare innovation sectors

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $38.00M 5
Khosla Ventures Kairos Ventures Bison Ventures
Khosla Ventures, Kairos Ventures +3
22 Nov 2023
Seed Round $2.00M 1
Kairos Ventures
Kairos Ventures
11 Mar 2021

Latest News

View All
This startup is training an AI model on skin that stays alive for a month — Thenextweb
This startup is training an AI model on skin that stays alive for a month
Thenextweb Aug 22, 2026

FAQ About Vivodyne

We accelerate the discovery of cures to human diseases with ultra-scalable drug testing on lab-grown human tissues.
Vivodyne was founded in 2020.
Vivodyne is headquartered in Philadelphia, United States.
Vivodyne operates in Biotechnology and Lifestyle. Its work centres on drug discovery, robotic systems, cellular therapies and lab-grown tissues. Its customers include Biopharma companies, Pharmaceutical researchers and Drug developers.
Vivodyne has a B2B, Platform and SaaS business model. Its revenue comes from Service Fee, Usage Based and Performance Based.
Vivodyne has approximately 40 employees.
Vivodyne has completed 2 funding rounds, raising a total of $40.00M. The latest funding stage is Seed.
Vivodyne offers: Development of lab-grown human organ models, AI-driven drug discovery and testing, Automation of massive-scale human tissue studies, Provision of preclinical human data for new therapies.

Source: BounceWatch company record for Vivodyne, https://bouncewatch.com/company/vivodyne, updated 4 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes